Examkin

Soru

Zorluk: ZorInfectious Diseases

A 42-year-old man presents to the emergency department with a 4-week history of a persistent productive cough, subjective low-grade fevers, drenching night sweats, and an unintentional 5-kg (11-lb) weight loss. He immigrated to the United States from Southeast Asia five years ago. His vital signs are temperature 38.1°C (100.6°F), blood pressure 118/76 mmHg, heart rate 92/min, and respiratory rate 18/min. A portable chest radiograph performed in the emergency department demonstrates a 3-cm cavitary lesion in the apical segment of the right upper lobe. The patient is currently resting in a standard emergency department examination room with the door closed.

Arrange the following interventions in the most appropriate chronological sequence for the comprehensive management of this patient.

  1. 1Transfer the patient to a negative-pressure airborne infection isolation room
  2. 2Collect three sputum specimens spaced 8 to 24 hours apart for mycobacterial evaluation
  3. 3Initiate an empiric antituberculous regimen with isoniazid, rifampin, pyrazinamide, and ethambutol
  4. 4Coordinate with local public health authorities to arrange directly observed therapy (DOT)
  5. 5Narrow the antimicrobial regimen to isoniazid and rifampin for the continuation phase

Cevap

The correct chronological sequence is to first isolate the patient in a negative-pressure room, followed by collecting diagnostic sputum samples, initiating empiric four-drug therapy, coordinating with public health for directly observed therapy prior to discharge, and finally narrowing the regimen to two drugs after two months.
The management of suspected active pulmonary tuberculosis requires a multidisciplinary, stepwise approach designed to protect the public while definitively treating the patient. The absolute first step upon suspecting active pulmonary tuberculosis (suggested by the classic presentation of an upper lobe cavitary lesion, weight loss, night sweats, and endemic geographic history) is to place the patient in an airborne infection isolation room. Delaying isolation exposes healthcare workers and other patients to aerosolized mycobacteria. Once isolated, diagnostic samples (acid-fast bacilli smears, cultures, and nucleic acid amplification) must be collected. It is a core principle of antibiotic stewardship to obtain these samples before antimicrobial administration to ensure high diagnostic yield and allow for accurate drug susceptibility testing. Immediately following sample collection, an empiric intensive-phase regimen of four drugs (rifampin, isoniazid, pyrazinamide, ethambutol) is initiated. Before the patient can be safely discharged back into the community, coordination with local public health authorities is mandatory to establish directly observed therapy (DOT), ensuring adherence and preventing multidrug-resistant strains. Finally, after two months of the four-drug intensive phase and confirmation of drug susceptibilities, the regimen is safely de-escalated to a two-drug continuation phase (typically isoniazid and rifampin).

Adım Adım Çözüm

1
Transfer the patient to a negative-pressure airborne infection isolation room.
Nosocomial transmission risk is immediately mitigated.
Airborne precautions are the absolute first priority in any patient with clinical and radiographic features suspicious for active pulmonary tuberculosis.
2
Collect three sputum specimens spaced 8 to 24 hours apart.
Diagnostic material is secured for AFB smear, NAAT, and mycobacterial culture.
Microbiological confirmation and drug susceptibility testing require high-quality samples obtained prior to the administration of any antimicrobial therapy to prevent false-negative cultures.
3
Initiate an empiric antituberculous regimen with isoniazid, rifampin, pyrazinamide, and ethambutol.
The 2-month intensive phase of treatment begins.
Prompt initiation of four-drug empiric therapy is indicated for highly suspicious cavitary disease immediately after diagnostic samples are secured.
4
Coordinate with local public health authorities to arrange directly observed therapy (DOT).
A structured outpatient adherence plan is established.
Systems-based practice dictates establishing DOT before hospital discharge to ensure treatment compliance and minimize the risk of developing multidrug-resistant tuberculosis (MDR-TB) in the community.
5
Narrow the antimicrobial regimen to isoniazid and rifampin.
The patient transitions to the continuation phase of therapy.
The standard continuation phase begins only after the 2-month intensive phase is completed, clinical improvement is noted, and susceptibilities confirm the absence of drug resistance.

Anahtar Kavram

The management of suspected active pulmonary tuberculosis follows a strict chronological pathway prioritizing airborne infection isolation, securing diagnostic microbiologic samples, initiating empiric multi-drug therapy, and ensuring public health coordination via directly observed therapy.
Tahmini Süre:2m 0s
Bu soruyu puanla

Konular

Infectious Diseases

Bu konudan daha fazla soru